| scholarly article | Q13442814 |
| editorial | Q871232 |
| review article | Q7318358 |
| P50 | author | Sundeep Mishra | Q114406264 |
| P2860 | cites work | Effect of antihypertensives on sexual function and quality of life: the TAIM Study | Q48907034 |
| Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial | Q57274347 | ||
| Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party | Q67588661 | ||
| Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial | Q68579824 | ||
| Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial | Q68934275 | ||
| Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial | Q69864810 | ||
| The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program | Q70434950 | ||
| Post-stroke antihypertensive treatment study. A preliminary result | Q70935260 | ||
| Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group | Q73733743 | ||
| The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure | Q73912535 | ||
| Why are physicians not prescribing diuretics more frequently in the management of hypertension? | Q74654835 | ||
| Risk of thiazide-induced hyponatremia in patients with hypertension | Q82138229 | ||
| Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 | ||
| Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension | Q24194532 | ||
| MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party | Q24541570 | ||
| Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack | Q28190600 | ||
| Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group | Q28328155 | ||
| Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects | Q28335101 | ||
| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 | ||
| Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). | Q31437386 | ||
| ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses | Q33576830 | ||
| Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis | Q34198795 | ||
| Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr | Q34628291 | ||
| 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34636529 | ||
| Treatment of hypertension in patients 80 years of age or older | Q34766135 | ||
| Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research | Q34768060 | ||
| Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients | Q37193241 | ||
| Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. | Q37832826 | ||
| Suppositions and speculations--their possible effects on treatment decisions in the management of hypertension | Q38260219 | ||
| Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses. | Q38285059 | ||
| New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension | Q38612904 | ||
| Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial | Q38899330 | ||
| Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification | Q39317741 | ||
| Trends in pharmacologic management of hypertension in the United States | Q40507045 | ||
| Current hypertension management: separating fact from fiction. | Q40881467 | ||
| Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics | Q41171838 | ||
| Hypertension and sudden death. Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias | Q43493838 | ||
| Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study | Q44316299 | ||
| Who really determines your patients' prescriptions? | Q44914747 | ||
| Diuretic therapy for hypertension and the risk of primary cardiac arrest | Q45285350 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 5 | |
| P921 | main subject | blood pressure | Q82642 |
| P304 | page(s) | 720-723 | |
| P577 | publication date | 2016-09-10 | |
| P1433 | published in | Indian heart journal : official publication of the Cardiological Society of India | Q26842841 |
| P1476 | title | Diuretics in primary hypertension - Reloaded | |
| P478 | volume | 68 |
| Q87967176 | Letter - Diuretics in primary hypertension - Reloaded |
| Q54846701 | Letter - Diuretics in primary hypertension - Reloaded. |
| Q54916705 | Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertension. |
| Q54864817 | Renoprotection with indapamide, additional feature to look for. |
| Q53499525 | The reduction in CVD outcomes with antihypertensives: A mandatory goal. |
| Q54840934 | Which diuretic for which hypertensive patient? |
Search more.